Patent · US Active

Tuberculosis compositions and methods of using the same

US11014969B2 · kind B2 · utility

0Cited by

4References

9Claims

0Family size

Assignee

International AIDS Vaccine Initiative, Inc. · US

Inventors

Ravi P. Anantha · Gaithersburg, US
Nathalie Cadieux · New York, US
Thomas G. Evans · New York, US
Michele Stone · New York, US
Barry Walker · New York, US

Key dates

Filing date	Mar 1, 2019
Grant date	May 25, 2021
Priority date	—
Expiry date	Mar 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.